DexCom (DXCM) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $80.26 -6.39%
Revenue Growth %: +9.9%
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Revenue Growth %: +9.9%
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of ($0.10), $0.08 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $242.5 million versus the consensus estimate of $205.68 million.
GUIDANCE:
DexCom sees FY2018 revenue of $925 million, versus the consensus of $862.2 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
- Medpace beats Q3 estimates but guides below on revenue
- Liberty Oilfield Services (LBRT) Misses Q3 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
